Speaking at the STAT Summit, Kyle and Nicole Muldoon shared an inside look at how their family went from heartbreak to ...

With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.

Gene editing has moved from labs to real world trials as scientists tweak DNA to cure disease, boost resilience, and redesign ...

The cost of sequencing DNA has dropped dramatically, and with technologies like CRISPR, gene editing is becoming more precise ...

CRISPR-edited insulin cells restore natural insulin in a Type 1 diabetes patient without rejection or immunosuppressants, ...

Gene editing, led by CRISPR, is expanding rapidly beyond medical applications, offering new opportunities across various biotech industries. Technological breakthroughs are fueling acceleration and ...

As developers of gene editing therapies and other genetic medicines get set to report third quarter earnings in coming days, analysts and especially investors will keep their eyes on whether the ...

US-based Cibus Inc will provide its gene editing technologies in partnership with industry and government stakeholders in ...

The latest in a trend of companies stepping back from cell and gene therapies amid regulatory uncertainty and manufacturing ...

Mexican scientists call for regulations to distinguish between gene-edited and genetically modified (GM) crops.

Scientists have been working to develop gene-editing technologies that can work within mitochondria. Mitochondria are ...

Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...